While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

In R&D, leadership changed for the first time in 15 years, with Mikael Dolsten stepping down, and the team underwent a restructuring. Bourla also highlighted returns to shareholders, including ...

He is replacing Dr Mikael Dolsten whose departure from Pfizer was announced in July, bringing a 15-year-plus career at the pharma group to a close, effective 1st January. The shake-up in Pfizer's ...

and after Pfizer chief scientific officer and president of R&D Mikael Dolsten also announced his intention to step down in the next few months after a successor is appointed. Parsey joined Gilead ...

"My mom had just passed away, and I saw a familiar face in the coffee shop. It was Mikael Backlund. This is a guy that I was drafted with. I played against him in juniors, and I also played ...